CA2142154A1 - Sulfated .alpha.-glycolipid derivatives as cell adhesion inhibitors - Google Patents

Sulfated .alpha.-glycolipid derivatives as cell adhesion inhibitors

Info

Publication number
CA2142154A1
CA2142154A1 CA002142154A CA2142154A CA2142154A1 CA 2142154 A1 CA2142154 A1 CA 2142154A1 CA 002142154 A CA002142154 A CA 002142154A CA 2142154 A CA2142154 A CA 2142154A CA 2142154 A1 CA2142154 A1 CA 2142154A1
Authority
CA
Canada
Prior art keywords
compound
solvate
hydrate
benzoyloxy
octadecene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002142154A
Other languages
English (en)
French (fr)
Inventor
Alain Martel
Jacques Banville
Alejandro A. Aruffo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2142154A1 publication Critical patent/CA2142154A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA002142154A 1994-03-04 1995-02-09 Sulfated .alpha.-glycolipid derivatives as cell adhesion inhibitors Abandoned CA2142154A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20592894A 1994-03-04 1994-03-04
US08/205,928 1994-03-04

Publications (1)

Publication Number Publication Date
CA2142154A1 true CA2142154A1 (en) 1995-09-05

Family

ID=22764246

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002142154A Abandoned CA2142154A1 (en) 1994-03-04 1995-02-09 Sulfated .alpha.-glycolipid derivatives as cell adhesion inhibitors

Country Status (15)

Country Link
US (1) US5663151A (OSRAM)
EP (1) EP0671407A2 (OSRAM)
JP (1) JPH0841093A (OSRAM)
KR (1) KR950032258A (OSRAM)
CN (1) CN1112122A (OSRAM)
AU (1) AU1360595A (OSRAM)
CA (1) CA2142154A1 (OSRAM)
CZ (1) CZ49895A3 (OSRAM)
FI (1) FI951001A7 (OSRAM)
HU (1) HUT70404A (OSRAM)
IL (1) IL112756A0 (OSRAM)
NO (1) NO950763L (OSRAM)
PL (1) PL307524A1 (OSRAM)
RU (1) RU95103100A (OSRAM)
ZA (1) ZA95937B (OSRAM)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957107B1 (en) * 1996-05-16 2004-07-21 Nissin Food Products Co., Ltd. Novel compounds having antiviral activity
US5700458A (en) 1996-09-20 1997-12-23 Geltex Pharmaceuticals Inc. Acid-functionalized saccharides as polyvalent anti-infectives
DE19700774A1 (de) * 1997-01-13 1998-07-16 Hoechst Ag Antiadhäsive Sulfatid-Mimetika
US7084122B2 (en) 2001-11-21 2006-08-01 Erik Larsen Use of glycosides of mono- and diacyglycerol as anti-inflammatory agents
CA2486106C (en) 2002-05-16 2013-07-16 Glycomimetics, Inc. Compounds and methods for inhibiting selectin-mediated function
WO2004004636A2 (en) * 2002-07-03 2004-01-15 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis
US20040219158A1 (en) * 2003-05-02 2004-11-04 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
CA2546784A1 (en) * 2003-11-19 2005-06-16 Glycomimetics, Inc. Glycomimetic antagonists for both e- and p-selectins
WO2005051920A2 (en) * 2003-11-19 2005-06-09 Glycomimetics, Inc. Specific antagonist for both e- and p-selectins
US7481080B2 (en) * 2004-07-01 2009-01-27 General Electric Company Clothes washer braking method and apparatus
DE102004036213B4 (de) * 2004-07-26 2011-02-24 Johannes-Gutenberg-Universität Mainz Nichtglykosidische und nichtpeptidische Selektininhibitoren, deren Herstellung und pharmazeutische Zusammensetzungen
US7923013B2 (en) * 2004-12-28 2011-04-12 The Rockefeller University Glycolipids and analogues thereof as antigens for NKT cells
US7534434B2 (en) * 2004-12-28 2009-05-19 The Rockefeller University Glycolipids and analogues thereof as antigens for NK T cells
WO2006127906A1 (en) * 2005-05-25 2006-11-30 Glycomimetics, Inc. Heterobifunctional compounds for selectin inhibition
US7517980B2 (en) * 2005-08-09 2009-04-14 Glycomimetics, Inc. Glycomimetric inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from Pseudomonas
ES2651929T3 (es) 2005-09-02 2018-01-30 Glycomimetics, Inc. Inhibidores de pan-selectina heterobifuncionales
WO2007143052A1 (en) * 2006-06-01 2007-12-13 Glycomimetics, Inc. Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
US7964569B2 (en) 2006-10-12 2011-06-21 Glycomimetics, Inc. Glycomimetic replacements for hexoses and N-acetyl hexosamines
EP2457573A1 (en) * 2007-02-09 2012-05-30 GlycoMimetics, Inc. Methods of use of glycomimetics with replacements for hexoses and N-Acetyl hexosamines
US8039442B2 (en) 2007-07-18 2011-10-18 Glycomimetics, Inc. Compounds and methods for treatment of sickle cell disease or complications associated therewith
EP2205616B3 (en) 2007-10-16 2020-01-22 Progen PG500 Series Pty Ltd. Novel sulfated oligosaccharide derivatives
US8895510B2 (en) * 2008-04-08 2014-11-25 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
ES2426784T3 (es) * 2008-06-13 2013-10-25 Glycomimetics, Inc. Tratamiento de cánceres de la sangre usando compuestos glicomiméticos seleccionados
CA2760292A1 (en) * 2009-05-01 2010-11-04 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
US8921328B2 (en) 2010-09-14 2014-12-30 Glycomimetics, Inc. E-selectin antagonists
EP2794626B3 (en) 2011-12-22 2020-08-05 GlycoMimetics, Inc. E-selectin antagonist compounds
SI2928476T1 (en) 2012-12-07 2018-06-29 Glycomimetics, Inc. COMPONENTS, INSTALLATIONS AND PROCEDURES OF THE APPLICATION OF E-SELECTINE OF ANTAGONISTS FOR THE MOBILIZATION OF HEMATOPOETIC CELLS
HUE045542T2 (hu) 2014-12-03 2019-12-30 Glycomimetics Inc E-szelektinek és CXCR4 kemokin receptorok heterobifunkcionális inhibitorai
CA3009836A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
WO2017151708A1 (en) 2016-03-02 2017-09-08 Glycomimetics, Inc. Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
WO2018031445A1 (en) 2016-08-08 2018-02-15 Glycomimetics, Inc. Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4
BR112019006642A2 (pt) 2016-10-07 2019-07-02 Glycomimetics Inc antagonistas multiméricos de e-selectina altamente potentes
CA3054605A1 (en) 2017-03-15 2018-09-20 Glycomimetics, Inc. Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
EP3717013A1 (en) 2017-11-30 2020-10-07 GlycoMimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
JP7304863B2 (ja) 2017-12-29 2023-07-07 グリコミメティクス， インコーポレイテッド Ｅ－セレクチンおよびガレクチン－３のヘテロ二機能性阻害剤
KR20200128025A (ko) 2018-03-05 2020-11-11 글리코미메틱스, 인크. 급성 골수성 백혈병 및 관련 병태의 치료 방법
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1164388A (en) * 1966-06-14 1969-09-17 Shionogi & Co Crystalline Sulfur-Containing Glycolipid and the Production Thereof.
EP0146810A3 (de) * 1983-12-05 1987-05-13 Solco Basel AG Verfahren zur Herstellung von Sphingosinderivaten
EP0212400B1 (de) * 1985-08-13 1992-01-02 Solco Basel AG Neues Verfahren zur Herstellung von Sphingosinderivaten
IT1235162B (it) * 1988-12-02 1992-06-22 Fidia Farmaceutici Derivati di lisosfingolipidi
JPH0317020A (ja) * 1989-06-14 1991-01-25 Nippon Koutai Kenkyusho:Kk 抗ｈｉｖ剤
AU660627B2 (en) * 1990-07-17 1995-07-06 Board Of Regents Of The University Of Oklahoma, The Functionally active selectin-derived peptide for GMP-140
DK84691D0 (da) * 1991-05-07 1991-05-07 Karsten Buschard Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater
WO1993005803A1 (en) * 1991-09-25 1993-04-01 Genetics Institute, Inc. Anti-inflammatory selectin inhibitors
US5326752A (en) * 1991-11-27 1994-07-05 Glycomed Incorporated Substituted lactose and lactosamine derivatives as cell adhesion inhibitors

Also Published As

Publication number Publication date
FI951001L (fi) 1995-09-05
NO950763L (no) 1995-09-05
CZ49895A3 (en) 1995-12-13
HU9500655D0 (en) 1995-04-28
EP0671407A2 (en) 1995-09-13
NO950763D0 (no) 1995-02-28
JPH0841093A (ja) 1996-02-13
IL112756A0 (en) 1995-05-26
KR950032258A (ko) 1995-12-20
HUT70404A (en) 1995-10-30
ZA95937B (en) 1996-08-06
PL307524A1 (en) 1995-09-18
EP0671407A3 (OSRAM) 1995-10-25
FI951001A7 (fi) 1995-09-05
AU1360595A (en) 1995-09-14
US5663151A (en) 1997-09-02
RU95103100A (ru) 1997-03-20
FI951001A0 (fi) 1995-03-03
CN1112122A (zh) 1995-11-22

Similar Documents

Publication Publication Date Title
CA2142154A1 (en) Sulfated .alpha.-glycolipid derivatives as cell adhesion inhibitors
US5686426A (en) Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
US5747463A (en) Malonate derivatives of glycolipids as cell adhesion inhibitors
US5783693A (en) Methods for synthesizing sulfated disaccharide inhibitors of selectins
EP0536969A2 (en) Anti-endotoxin compounds
WO1997030984A1 (en) Sialyl lewisx mimetics containing phenyl backbones
WO1997031006A1 (en) SIALYL LEWISx MIMETICS CONTAINING NAPHTHYL BACKBONES
US5962660A (en) Sialyl Lewis X mimetics incorporating fucopeptides
US5869460A (en) Sulfated and phosphated saccharide derivatives, process for the preparation of the same and use thereof
US5565433A (en) Sulfated β-glycolipid derivatives as cell adhesion inhibitors
US5264567A (en) GM3 analogous compound
Veeneman et al. Synthesis of an immunologically active component of the extracellular polysaccharide produced by Aspergillus and Penicillium species
US5220008A (en) Oligosaccharide inhibitors for influenza virus
US5254676A (en) Oligosaccharide inhibitors for influenza virus
AU2007303858A1 (en) Anticoagulant compounds
US5358936A (en) Anionic furanose derivatives, methods of making and using the same
JP4913272B2 (ja) オリゴ糖の製造方法ならびに新規オリゴ糖およびそれを含む医薬組成物
EP0560055B1 (en) Immuno-suppressing enepyranose derivatives
Peter Wessel et al. The Synthesis of the 3′-and 3′′′-Monodeoxygenated Derivatives of β-Maltosyl-(1→ 4)-Trehalose
US6562954B1 (en) Method for producing oligosaccharide, and novel oligosaccharide and pharmaceutical composition containing the same
WO1994017084A1 (en) Disaccharide ligands
AU641540C (en) Anionic furanose derivatives, methods of making and using the same
Auzanneau et al. Chemistry of bacterial endotoxins. Part 6. Synthesis of allyl 5-O-(α-D-mannopyranosyl)-(3-deoxy-α-D-manno-oct-2-ulopyranosid) onic acid and of allyl 5-O-(α-D-mannopyranosyl)-(3-deoxy-α-D-manno-oct-2-ulopyranosid) onic acid 4-phosphate and their copolymers with acrylamide
JPH1045793A (ja) 二量体化合物
TW200413400A (en) Lipid a derivatives which have glucose back-bone as the reducing sugar part

Legal Events

Date Code Title Description
FZDE Discontinued